Adalimumab Injection
Adalimumab Injection is a pharmaceutical drug with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Subconjunctival Humira for Boston Keratoprosthesis
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis
The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Clinical Trials (9)
Subconjunctival Humira for Boston Keratoprosthesis
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis
The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
The Clinical Efficacy of Immunomodulators in RA Patients
Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9